Categories: Analysts

Saj Karsan: Calian Technologies ticks all the Joel Greenblatt boxes

Will Calian Technologies be the little Canadian tech stock that beats the market? Value investor Saj Karsan says it meets the criteria of Joel Greenblatt's book.

Technology companies are generally more difficult to value than their counterparts in more stable industries. Because of the disruptive nature of change in the tech industry, it’s very difficult to forecast earnings a few years out with any degree of certainty. But there are properties a company can possess, even one in the technology industry, that add some certainty to the valuation. A large cash balance is one of them.

Consider Calian Technologies (TSX:CTY), a provider of technology products and services for the communications industry. Calian has a cash balance of $25 million against no debt, which results in cash comprising 17% of the company’s market cap!

So while the company trades at a price to earnings ratio of 11, it’s price to earnings ratio becomes just 9 if the cash is backed out of the company’s market cap. The P/E is low despite the high returns on equity the company generates; ROE has been around 20% for many years in a row. Meanwhile, the company paid out $15 million in cash to shareholders last year (in a combination of buybacks and dividends), which is about 10% of the company’s market cap.

The cash balance is not the only thing helping stabilize the value of this business, however. The company signs a number of contracts in advance, so much so that it has a backlog of almost $900 million. Compare this to the company’s 2010 revenue of just over $200 million.

Furthermore, most of the company’s revenue (and a significant portion of profit) comes from supplying labour services (e.g. engineering professionals). This reduces the company’s technology risk, as this segment does not have to constantly create a better mousetrap in order to stay competitive.

However, an investment in Calian is not without risk. Almost two thirds of the company’s business comes from the Federal Government of Canada. As such, spending cuts or shifts in priorities away from initiatives requiring Calian’s services would have a dramatic effect on the company’s business and profitability. It’s also worth pointing out that the large backlog number is not calculated conservatively, as it includes the value of buyer options, which may or may not be exercised.

To make money over the long-term, investors should seek out companies with high returns on equity with low P/E ratios, as discussed in Joel Greenblatt’s, The Little Book That Beats The Market. At Calian’s current price, it appears to fit the bill, with a large cash balance as a bonus.

Disclosure: None

Saj Karsan co-founded an investment and research firm that is based on the principles of value investing. He has an MBA from the Richard Ivey School of Business, has completed all three CFA exams, and has an engineering degree from McGill University. Visit his blog, Barel Karsan

_____________________________________________________________________________________

_____________________________________________________________________________________

Tagged with: cty
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Tilray: why this analyst just cut his price target

Haywood Securities analyst Neal Gilmer says lower Canadian cannabis market share is weighing on Tilray Brands (Tilray Brands Stock Quote,… [Read More]

14 hours ago

Why National Bank likes Anaergia right now

National Bank Financial analyst Baltej Sidhu says Anaergia’s (Anaergia Stock Quote, Chart, News, Analysts, Financials TSX:ANRG) divestiture of two legacy… [Read More]

14 hours ago

Canada’s provinces are leading investment boom, RBC says

RBC assistant chief economist Cynthia Leach says the public sector is playing a larger role in Canada’s investment boom than… [Read More]

14 hours ago

Can Eupraxia Pharmaceuticals stock go even higher?

Research Capital analyst Andre Uddin says Eupraxia Pharmaceuticals (Eupraxia Pharmaceuticals Stock Quote, Chart, News, Analysts, Financials TSX:EPRX) reported another strong… [Read More]

14 hours ago

Is it time to buy VersaBank stock?

Roth Capital Partners analyst Craig Irwin says VersaBank (VersaBank Stock Quote, Chart, News, Analysts, Financials NASDAQ:VBNK) is nearing a potential… [Read More]

14 hours ago

Rapid Micro Biosystems has a 240% upside, this analyst says

Roth Capital Partners analyst Max Masucci says Rapid Micro Biosystems (Rapid Micro Biosystems Stock Quote, Chart, News, Analysts, Financials NASDAQ:RPID)… [Read More]

14 hours ago